Recent studies proved that the aberrant expression of individual MYC target genes is involved with osteosarcoma initiation, progression, and metastasis and thus serves as a predictive and prognostic biomarker for osteosarcoma (32–35). The gene discussed is MYC; the disease is osteosarcoma.